These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8635614)

  • 1. More on cancer screening.
    Chodos J
    Del Med J; 1996 Apr; 68(4):235-6. PubMed ID: 8635614
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening concerns.
    Frelick R
    Del Med J; 1996 Apr; 68(4):233-4. PubMed ID: 8635613
    [No Abstract]   [Full Text] [Related]  

  • 3. [Screening with PSA (Prostate Specific Antigen) raises ethical questions].
    Taube A
    Lakartidningen; 1996 Sep; 93(39):3341. PubMed ID: 8926796
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prostate cancer screening using prostate specific antigen (PSA) in Tokatsu Hospital--examination of lost-to-followup cases].
    Shimizu N; Yamanaka H; Ichinose Y; Saitou Y
    Hinyokika Kiyo; 1998 Mar; 44(3):155-8. PubMed ID: 9589875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
    Meyers FJ; DeVere White RW
    West J Med; 1998 Jun; 168(6):525. PubMed ID: 9655997
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mass screening for prostate cancer in Nagano].
    Ishizuka O; Satoh T; Kobayashi S; Nishizawa O
    Hinyokika Kiyo; 2001 Nov; 47(11):769-72. PubMed ID: 11771167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for prostate cancer. A consumer view.
    Gardner M
    Aust Fam Physician; 2003 Jun; 32(6):398-9. PubMed ID: 12833762
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mass screening for prostate cancer will have to wait. The scientific basis insufficient, more efficient markers necessary].
    Damber JE
    Lakartidningen; 2003 Sep; 100(38):2916-8, 2921. PubMed ID: 14558209
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on screening for prostate cancer with prostate-specific antigen.
    Schmid HP; Riesen W; Prikler L
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legal implications of prostate cancer: what you should know.
    Reeves JD; Schellhammer PF
    Va Med Q; 1993; 120(2):77-9. PubMed ID: 7683209
    [No Abstract]   [Full Text] [Related]  

  • 11. Is screening for prostate cancer the current gold standard?--"yes".
    Lange PH
    Eur J Cancer; 1997 Mar; 33(3):354-6. PubMed ID: 9155516
    [No Abstract]   [Full Text] [Related]  

  • 12. PSA testing.
    Frydenberg M
    Aust Fam Physician; 2003 Jun; 32(6):396. PubMed ID: 12833760
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
    Hamilton RJ; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
    [No Abstract]   [Full Text] [Related]  

  • 14. Best screening tests for prostate cancer.
    Moul JW
    West J Med; 1998 Aug; 169(2):109-10. PubMed ID: 9735692
    [No Abstract]   [Full Text] [Related]  

  • 15. Is screening for prostate cancer the current gold standard?--"no".
    Kramer BS; Gohagan JK; Prorok PC
    Eur J Cancer; 1997 Mar; 33(3):348-53. PubMed ID: 9155515
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum prostate specific antigen for the early detection of prostate cancer in outpatients of internal medicine].
    Otani T; Hayashi Y; Ikuno Y; Hirao Y; Ozono S; Okajima E
    Hinyokika Kiyo; 1996 Sep; 42(9):645-9. PubMed ID: 8918662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How valuable is prostate-specific antigen screening?
    Handler S
    Minn Med; 1996 Jun; 79(6):2. PubMed ID: 8692130
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient education. PSA: pros and cons.
    Gattellari M; Ward JE
    Aust Fam Physician; 2003 Jun; 32(6):429-30. PubMed ID: 12833769
    [No Abstract]   [Full Text] [Related]  

  • 19. PSA: prostate-specific antigen, persisting scientific ambiguities.
    Harv Mens Health Watch; 2009 Jul; 13(12):1-6. PubMed ID: 19718841
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for prostate cancer. Why can't the clock be turned back?
    Addy DP
    BMJ; 1998 Jun; 316(7148):1904. PubMed ID: 9669858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.